Member Info for roger65

Need the funding issue dealt with to surge. Going to take time to generate sales income and they run out of cash end of June. This simply has to be dealt with sooner rather than later.

We know full NICE recommendation will (hopefully +ve) will arrive end of March. The only thing that could give the sp a shot in the arm right now would be some good news on the FDA pre submission discussions that took place in mid December. We are due an update on that any time now. If we qualify for one of the fast track routes then this flies up to 40p+ and Budd will hopefully get a placing in then at a decent level. Hope that might be at about 30p but probably being a tad optimistic.

If that all happened though then we'll be up towards 60p just before the end of March. Just thinking aloud. It's a refreshing change to be optimistic on GDR!

OK your post is well reasoned Legalw. I can't argue about the bear market that we're enduring currently, or sentiment for junior explorers being poor. Essentially imho POW just haven't focused on any one area to stand a realistic chance of discovering something interesting. PJ dips his toes in, makes it sound exciting but then it turns out not be, and goes back to the business model of IPOs spinouts and being a company that exists mostly thanks to bits of paper rather than actually having anything in the ground they can shout about. They have licenses but absolutely nothing to sell or tempt a jv partner with at the mo. It is what it is and I've resigned myself to just having to hold here for another few years before a bull market and sentiment return and PJ and his teams get lucky and actually discover something in the ground other people want/need to buy. Also agree there are no NDAs in place at the mo. That's just a desperate excuse by some to explain the ongoing silence from PJ. No more shout outs via twitter. Just another lecture in the emails sent out by the company to its investors on the virtues of being spread thinly across many metals and jurisdictions. I'm in PJ's hands so i hope he's got something up his sleeve to bring back the buzz here sooner rather than later.

When I say 'everyone's doing it' I'm referring to Lithium. Surely KDNC has something that will be of interest to someone else? KM can't do anything with this Sonora license himself so please God he tries to sell it or get a jv partner in and gets a shift on or KDNC is gonna end up missing the boat here.

Everyone's doing it....look at CLON. Announced a jv partner and they're currently up 60%.

I do hope Kieran can pull something off in all of this current period of discussions/negotiations. I'll be well hacked off if Ganfeng end up with a great deal and KDNC is left out in the cold. It's always possible but am I being naive to hope Ganfeng might try to take out KDNC's 30% to make their lives easier in dealing with the Mex Govt?

Who ever posted it earlier I think is right in that this will now hover between 25 - 28p tange until news at the end of March. It's the funding issue holding it back for now and Budd doesn't seem bothered about letting share holders know what he's planning. A placing at 20p could land any minute or they could wait until end of March for further NICE news or the update from FDA pre submission. The longer the silence on this funding issue - and Budd has amazing form on staying silent on key matters for months and months - the closer we get to running out of cash at the end of June and that presumably weakens GDR's negotiating position. I'd now prefer them to get it out of the way so everyone can start to build positions and commit to them knowing the runway for the next year at least is clear and looking really good for a year hence...

I was not too far off getting back in the blue but after the last three weeks I'm horribly down again. Got 9m shares in this and need it - really need it - to fight back but got that sinking feeling that PJ has done a number on share holders here. he'll argue he's the biggest share holder here but that's his stake money if you like and he's probably never going to take it out unless the sp does something crazy like shoot up to 10p and I can't see it ever doing that!

2.5p please. And I'm then out and wish PJ well. I do like him as a character and think he comes across as genuine. He's just out of his depth compared to others in this space and one of POW's best assets at the moment is what comes out of his mouth. That can only last so long though before the walls come tumbling down. Back to IPOs to try and generate some money for POW.

ffs!! Why has it got to bounce back in the next two days? Regardless of all the positives the BOD clearly said they would have to get more funding. It's that that is stopping retail piling in big time and also iis I'm sure. They've said they'll do it and the most likely and easiest way is via a placing and their track record is to do them at punitive discounted rates eg 40% below prevailing share price.

Unless Budd can come to the market and say we've got funding via another source and, by the way, there's good news from the FDA pre submission discussions held in mid December, then investors will stay their hands. Some may try to do quick trades to get their averages down - remember most lths here will be well under water, OR they will simply wait to hear where the next load of cash is coming from before buying in. Yes, they risk missing out if there's a ton of good news but Budd and Gilham have history in not looking after their share holders. Promise much. Deliver very little (until now that is). Watch the sp fly in to the £s and then stay silent as it drops all the way to flipping 8p!

I for one don't believe for a second that post was really from david Budd. It would be the first time I've EVER seen a CEO post on the LSE or any other posting forum. He's shown he's not aligned with share holders but at least things are now looking much rosier for GDR. It's the funding issue that will prevent any 'bounce back tomorrow or Thursday'.

Personally I'm trying to wiggle things about in order to buy more but at a slightly lower price. I'd set myself a target of 25p but decided today just to get more and not play silly buggers. As for the rest of my holding here it's staying put. Too great a risk of losing out and too stressful to think about it every second of every day. All will be well here but just not in the next 5 minutes, days or weeks. In 5 months I think the sp will be at least double where it is so this is for me a great time to be in heavily.

they were forced en-masse to buy a % of their salaries by the looks of it back in Oct 2021.

Budd bought £25k worth and now holds about 350k. I hold more than he does and I'm sure there are many pis posting here who do as well.

I'm making an assumption the results are not what we hoped for AS01. i didn't say PJ would inform Thor on what results might look like, but simply that if they 'had any notion', be that based on a hunch or interpreting PJ's latest interview and lack of general noise from POW about MFC. Nothing to say I'm right. Hope I'm wrong but this is an incredibly risky stock. rewards can be great but it's all based on large dollops of luck. We would have heard something positive from PJ by now if there were positive signs.

In fact my next worry isn't MFC results being poor or even Thor selling out, it's when and what level the next placing comes along. There are already 1.7b shares in issue and it slowly but surely keeps growing. With no positive results from any exploration campaigns POW becomes more and more an accountant's paper shuffling exercise - IPO's, buying/selling %s of licenses held by this company or that company.

Had really hoped for a great first Q but we're 6 weeks in and things aren't looking great. SP is down significantly and looking to go back to under a penny. 'Transformational' ? Not yet, by a long shot! Maybe in 2024.

...can make the sp spring back into life now and that's some positive news on the FDA pre submission discussion. Further NICE news is 6 weeks away.

If an RNS lands saying we can opt for the de Novo route in the US - imho this is what should happen - then we will know the likely costs and timings before sales fall into place. Both will greatly increase interest in GDR stock. Again, just my take, but I think if we did hear this good news and the sp spiked again then that would be the time for the BODs to go for a placing. If we could lurch our way to 40p and then do a placing at a 25% discount we'd be sitting pretty at 30p with a nice clear road ahead for the next 12 months.

If news from FDA isn't so great then the raise will likely happen immediately and if the prevailing sp is 25p then I think we'd be knocked back to 15 - 18p but...then that lovely open horizon opens up and we'll be on our way, so all good either way.

There will be a fund raise. Sales will take time to generate the income GDR needs to move forward. The fund raise is coming we know for sure and without any sales contrqcts yet in place I can't see a jv partner coming on board or a knock-out buyout offer landing. Any pharma is going to want to know they're purchasing not only the technology but the sales canvass too. The more territories where contracts exist, even if it's only one in each of them then the greater the chance the big lads will be looking over GDR with a keen eye. News of NHS Trusts adopting AIHL and positive FDA news and the pharmas will suddenly be sniffing.

Either share holders just stick with their gut and hold knowing things will look a lot rosier in 6 - 12 months time or they take a risk in selling now to try and buy back in lower. It's a big gamble. What doesn't seem like a gamble to me at the moment is anyone buying in now willing to leave their investment alone for at least 6 months. No cast iron guarantees but I'm putting a lot of money on the line here that the sp will be hopefully at least double where it is by at least September. If any offers to buy out GDR land though then all bets are off and I've no idea how high the sp could go.

GLA

1.8 the bottom? Really? TP still have another c15m shares to dump and then we can look forward to a fund raise at an ugly discount.... Wouldn't be surprised to see the sp drop further as low as 1.5p and then hopefully enough retail will kick in to see off the effects of TP selling...but then there's the issue of funding hanging over everyone's heads.

Tray: your advocacy and pro POW stance is admirable, if not a little misguided.

Looks to me as if the market has a strong inkling the MFC results are duff and with Thor continuing to sell their holding - why would they sell right now if they had any notion MFC results would make the value of their shares jump - this is sadly looking as if it's back to sub 1p. I did say a while ago that after all the PJ hype and talk of 'transformational' results that if they turned out to be bad it would damage PJ's reputation quite seriously and hamper POW's chances going forwards of any more cash raises at very small discounts. Once we're sub penny I think we can expect further cash raises but at a more punitive discount. Once Thor are out that might provide a little respite but unfortunately PJ's attempts to blatantly ramp the stock prior to the MFC drills has not worked out well. Shame. I like the look of all this but there has been far too much paper work with IPOs etc and not enough core activity ie drilling, leading to discovery. Going to be a tough year for POW share holders imvho. Means TATI becomes a huge focus in the next few months.

Just my opinion but this line in the recent RNS suggests strongly to me that they've gathered useful info in this last drill but that they know it's not what they were hoping for.

'We expect the data and interpretations from this drill programme will add considerably to the existing understanding of what we believe is a particularly exciting opportunity at Molopo Farms.'

'...what we believe...' Means they still don't know if Molopo will be the discovery we all want. And they'll know enough from preliminary visual and XRF surveys of drill cores so I don't think they're totally blind going into this next phase whilst awaiting the actual results. This is a long hold. Tati stands to be a more exciting prospect in the near term imho. Probably wrong. Hope I am.

hmmm could be right Lloyd. Didn't try any dummy sells today.

Starres - the sp finished at 29.5p. Not above 30p but hey, splitting hairs.

I've got about 350k shares now. Used to be more but got cold feet when the sp plummeted to below 10p. If only I'd held...hey ho. Live and learn. Sometimes..

When this gets to £1 then I'm out and out for good. Not done my health any good this share so when people suggest DBudd deserves a pat on the back I'm fairly scornful. He's put lths through the mincer these last 3 and a half years and damaged his own credibility when making bold - and false - statements about contracts for the Covid PoC kits that either didn't exist or came to nought. Don't get me wrong I'm delighted with the current improvement and very much looking forward to the coming weeks/months but I hope GDR gets bought out for a huge sum and David Budd is booted out. His R&D team are the ones who have done brilliantly. Not him. Without their excellent work GDR would still be nowhere. says a lot about the guy that whilst all share holders since 2019 have most likely made a terrible loss and are still in the red he's been perfectly happy to walk away with a huge salary AND bonuses. I hope Gilham has someone lined up to buy GDR for £100m+ and that Budd is then on the hunt for a new job.

Good w/e all

...was pretty much all buys by the looks of things. In fact just shy of £100k of buys. So....how come the sp didn't budge? I have a nasty feeling we're about to learn of another large sell in the next hour or so and that has been worked through at the end of the day by the mms, probably hoping FOMO would kick in. Just my take on current sp shenanigans.

FDA news is due up next as far as I can tell and, depending on which way they decide GDR need to submit their application this is going to react strongly.

Hoping for De Novo and sp rockets up to 60p+. The US market is 5x that of the UK. The EU market is also 5x that of the UK. Japan alone is double. Middle East? The rest of Asia? Eye watering figures . C'mon FDA pull your finger out.

HL moved BId down to 28.5. Barsteward mms taking it down at the close. Plenty of buying but it's been decided...

Yes, reflecting in the fact he's going to have to work his ass off for a few more years before he sees any return on his investment in POW.....

I know the feeling.

Seems for all the world as if this outfit has shut up shop altogether. Starting to think I was right a couple of months back that they did the raise purely to pay for Directors' salaries and that once that money runs out they'll simply shut up shop.

'cat and mouse for a while then'The poor mouse has its legs tied together and cornered and the cat has sharpened its teeth and is hungry. Yeah, cat and mouse with TP. They've got EISB by the short and curlies and nothing Burt can say or do will prevent them from their play, what ever that might be. The only thing to me that makes any sense for TP selling down slowly at the mo is to drive sentiment in Burt to an all time low - to match the all time low share price - and go in with a low ball takeover bid. Can't see any other positive outcome for Burt. Just wish they'd get on with it and put the poor mouse out of its misery.

is imminent. This is NOT the FDA approval to sell we're waiting on, it's the outcome of the initial discussion on which route GDR can embark on with its AIHL test. With luck it will be De Novo route, which is by far the quickest and cheapest and I think (pls correct if wrong) means they could begin selling in the US immediately..? If that dropped now this would surge to over £1. Probably pull back 30p knowing what GDR share price is like but a huge spike would almost certainly ensue if De Novo was the upshot of those discussions in December.